• Avalo Therapeutics granted nonstatutory stock options covering 78,000 shares to six newly hired employees.
• Options were issued on Sept. 2, 2026 with an exercise price of $19.34 per share, set at the closing price.
• Vesting starts with 25% after one year from each employee’s start date, then monthly over 36 months.
• Awards were issued under the company’s 2025 Inducement Award Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalo Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609041605PRIMZONEFULLFEED9821244) on September 04, 2026, and is solely responsible for the information contained therein.